There are several small components used in hospitals, such as bio connectors and adaptors. These components are used on vascular access devices, urinary catheters, breathing ventilators, and other devices to connect medical devices to medications, fluids or other medical devices. These small, but critical, components are handled multiple times a day by healthcare workers caring for their patients and can often be overlooked as a possible source of cross-contamination. Recent studies on these components and their potential contribution to Healthcare-associated infections have led FDA to require post-market surveillance studies on several designs of needleless connectors due to concerns of increased risk of bloodstream infections with the use of these devices.
Protecting medical devices against the growth of microbes goes beyond the bigger, more obvious devices, and includes the smaller components and accessories such as these, which are frequently handled and accessed by healthcare workers. Agion® Antimicrobial is used as a trusted antimicrobial solution for bio connectors and adaptors to protect these components from microbial contamination.
Whether incorporated into the material itself, or used as a coating, Agion® Antimicrobial has the efficacy to provide lasting protection to these critical components used widely in hospitals. Agion has been shown in laboratory testing to be effective against some of the most concerning antibiotic resistant bacteria that are responsible for infections in our healthcare facilities. The 2014 strategies to prevent central-line associated bloodstream infection authored by the Society for Healthcare Epidemiology of America includes the use of Agion-treated central venous catheters.
For more information about Sciessent and how we can improve your implantable devices, please feel free to contact us.
The Agion® Antimicrobial is presently registered by the United States Environmental Protection Agency as a preservative and bacteriostatic agent for use in treated articles under 40 CFR 152.25a. The information presented herein is not intended to support or endorse public health claims for treated articles. The Agion Antimicrobial is also used in medical devices under the Food and Drug Administration in the US; those medical device claims are based on safety and efficacy testing and are limited to those approved by FDA. In the EU, the Agion Antimicrobial is used in medical devices under the Medical Device Directive: those medical device claims are based on safety and efficacy testing and are limited to those approved by the designated Competent Authorities and/or Notified Bodies.